- Country: Saudi Arabia
- Summary: Bismuth Subcitrate Potassium 140Mg/Metronidazole 125Mg/Tetracycline 125Mg Cap
- SAT Ref No: 104225565
- Deadline: 30 Jul 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: ORD0000187821
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- BISMUTH SUBCITRATE POTASSIUM 140MG/METRONIDAZOLE 125MG/TETRACYCLINE 125MG CAP
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBismuth Subcitrate Potassium 140Mg/Metronidazole 125Mg/Tetracycline 125Mg Cap - Saudiarabia Tender
The KING FAHAD HOSPITAL IN JEDDAH, a Government sector organization in Saudi Arabia, has announced a new tender for Bismuth Subcitrate Potassium 140Mg/Metronidazole 125Mg/Tetracycline 125Mg Cap. This tender is published on SaudiarabiaTenders under SAT Ref No: 104225565 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-07-30.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
